Stay updated on Pembrolizumab in RCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in RCC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added, replacing Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T15:25:37.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The page shows a new revision tag (v3.4.2) and removal of a prior government funding notice; no changes to the study details, outcomes, or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T09:27:06.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    A system notice about government funding lapse and NIH Clinical Center operations was added, and the site version updated to v3.4.1 (replacing v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-04T05:54:31.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Glossary toggle was added, and QC/version metadata updated to show 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. The older QC wording and 'No FEAR Act data' phrasing were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T03:30:43.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. The update affects page metadata and formatting but does not alter study details, participation criteria, or study results.
    Difference
    0.1%
    Check dated 2026-01-14T01:43:12.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Footer updates include adding 'Revision: v3.3.3' and removing the 'HHS Vulnerability Disclosure' link. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T08:20:03.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in RCC Clinical Trial page.